Kyverna Therapeutics, Inc. (KYTX)
9.45
+1.09
(+13.04%)
USD |
NASDAQ |
Dec 12, 11:12
Kyverna Therapeutics EPS Diluted (Quarterly): -0.8473 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.79M |
| Total Expenses (Quarterly) | 36.79M |
| Enterprise Value | 200.02M |
| Earnings Yield | -39.38% |
| Normalized Earnings Yield | -39.38 |